OLUMUYIWA IDOWU: Open Payments
NPI 1538254511 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 24 payments from 9 companies in 2025. Trend: 2023 $480 · 2024 $1,711 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 6 | $173 |
| Saxum Surgical, Inc. | 1 | $122 |
| Lilly USA, LLC | 3 | $95 |
| Teva Pharmaceuticals USA, Inc. | 3 | $84 |
| UCB, Inc. | 3 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Novo Nordisk Inc | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
Products named: JARDIANCE, AUSTEDO XR, Briviact, CAPLYTA, ACP, REXULTI, EXCELSIUS GPS, KISUNLA.
Industry payments across IL — which companies pay providers there.
